![Robert Arch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Arch
Presidente presso
Immunophotonics, Inc.
Profilo
Robert H.
Arch currently works at Immunophotonics, Inc., as President from 2025.
Dr. Arch also formerly worked at OncoSec Medical, Inc., as President, CEO & Non-Independent Director from 2022 to 2023, Elpiscience Biopharma Ltd., as Head-Research from 2019 to 2021, and China Novartis Institutes for BioMedical Research Co., Ltd., as Head-Liver Disease Department from 2017 to 2019.
Dr. Arch received his doctorate degree from Julius-Maximilians-Universität Würzburg.
Posizioni attive di Robert Arch
| Società | Posizione | Inizio |
|---|---|---|
Immunophotonics, Inc.
 Immunophotonics, Inc. Pharmaceuticals: MajorHealth Technology Develops proprietary novel drug product for use in a minimally invasive therapeutic cancer vaccine | Presidente | 22/09/2025 |
Precedenti posizioni note di Robert Arch
| Società | Posizione | Fine |
|---|---|---|
| ONCOSEC MEDICAL INCORPORATED | Amministratore Delegato | 14/06/2023 |
Elpiscience Biopharma Ltd.
 Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Develops cutting-edge immunotherapies to fight cancer | Direttore Tecnico/Scientifico/R&S | 01/06/2021 |
China Novartis Institutes for BioMedical Research Co., Ltd. | Corporate Officer/Principal | 01/10/2019 |
Formazione di Robert Arch
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
23
Relazioni di 1° grado
5
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
OncoSec Medical, Inc.
 OncoSec Medical, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel immunotherapeutic products for immuno-oncology treatment | Health Technology |
Immunophotonics, Inc.
Immunophotonics, Inc. Pharmaceuticals: MajorHealth Technology Develops proprietary novel drug product for use in a minimally invasive therapeutic cancer vaccine | Health Technology |
Julius-Maximilians-Universität Würzburg
 Julius-Maximilians-Universität Würzburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Elpiscience Biopharma Ltd.
Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Develops cutting-edge immunotherapies to fight cancer | Health Technology |
China Novartis Institutes for BioMedical Research Co., Ltd. |
